No Picture
News

HNRC UPDATES ON SECOND $100 MILLION DOLLAR SPAC

HOUSTON, TX, May 26, 2022 /PRNewswire/ — Houston Natural Resources Corp. (“HNRC or the Company”) provided an update on its strategy to invest and sponsor Special Purpose Acquisition Corporations (“SPACs”). The company intends to invest […]

No Picture
News

Reata Pharmaceuticals Announces FDA Filing Acceptance and Priority Review Designation for the NDA for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia

PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for filing and granted Priority […]

No Picture
News

Data Demonstrating DecisionDx®-Melanoma’s Ability to Risk-Stratify Patients According to Melanoma-Specific Survival to be Shared during the 2022 ASCO Annual Meeting

FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CSTL–Castle announced that an abstract regarding its DecisionDx®-Melanoma test will be available online during the upcoming 2022 ASCO Annual Meeting. Click here to view original post

No Picture
News

Study Finds that NeuFit® Neuromuscular Electrical Stimulation (NMES) May Produce Similar Results as Traditional High Load Training with Less Strain on Body

The real-world intervention trial observed acute indicators of muscle growth or strength improvements may be achieved with lower perceived exertion during exercise when training with the Neubie® NMES device. AUSTIN, Texas, May 25, 2022 /PRNewswire/ […]